Partners' COI rules overreach
While some applaud the revamp, the restrictions may be too broad and “could ultimately stifle” critical education, reports the Harvard Crimson.Industry-sponsored talks, now banned, provide docs with the latest information. Surgical training fellowships may suffer.
“The pendulum is a little too far in one direction,” one professor said. Pharma stock options are forbidden, and outside pay for senior officials has been capped.